Sweden Medical Device Registration

Navigating Medical Device Registration & Post-Market Surveillance in Sweden
The Medical Products Agency‘s goal is for users of medical devices to have access to safe devices that are suitable for their intended use.
The agency’s task is to carry out monitoring to ensure that relevant legislation in the medical device field is complied with. This monitoring will continue to take place via market surveillance through, inter alia:
The Medical Products Agency is responsible for reviewing planned clinical trials. The agency also conducts ongoing oversight of the designated notified bodies based in Sweden to ensure they are performing effectively and are retaining the necessary competence to undertake their designated activities.
The National Board of Health and Welfare is responsible for:
The Health and Social Care Inspectorate (IVO) supervises:
https://www.lakemedelsverket.se/en
Class I, IIa, IIb, III
https://www.lakemedelsverket.se/en/medical-devices/manufacture/registration#hmainbody8
Every user of a medical device in Sweden shall have access to information written in Swedish on the labelling and in the instructions for use. Information provided to the Authority shall be either in Swedish or English.
The National Board of Health and Welfare mandates that healthcare providers in Sweden report incidents involving medical devices to the Swedish Medical Products Agency (MPA). Reporting should be timely, rather than waiting for a comprehensive investigation. The initial report can be amended with latest information at a later stage, ensuring that the Swedish MPA and manufacturer are informed of any potential risks.
Effective medical device pms and vigilance helps manufacturers monitor device safety and address incidents after market placement.
A notification shall be submitted if any of the below has led to, or could have led to, death or serious deterioration in someone’s health:
If you are unsure whether an event falls within the reporting requirements, you should inform the manufacturer and the Swedish Medical Products Agency of the occurrence anyway.
Notifications are submitted with an e-service. The e-service is only available in Swedish.
The healthcare provider must retain the device for further investigation, including its UDI/batch number/LOT number, usage instructions, and packaging. The manufacturer must have access to the device for investigation. If necessary, the provider must provide additional information to the manufacturer and the Swedish Medical Products Agency.
Before placing a medical device into the market.
Contact us for free consultation: sales@omcmedical.com
The EU MDR sets requirements for medical device safety, performance, conformity assessment, CE marking and post-market surveillance. Manufacturers must meet these requirements before placing medical devices on the Swedish market.
Yes. Medical devices must meet the applicable EU MDR requirements and obtain CE marking before being placed on the Swedish market.
Economic operators may have registration and notification obligations with the Swedish Medical Products Agency (MPA), depending on their role and applicable requirements.
The EU MDR (2017/745) applies to medical devices, while the EU IVDR (2017/746) applies to in-vitro diagnostic medical devices.
Join hundreds of companies who trust OMC Medical for their regulatory needs.